1. Introduction
===============

Male infertility is a complicated disease globally, and is defined as the failure of a couple to achieve pregnancy after 1 year of unprotected, regular sexual intercourse.^\[[@R1],[@R2]\]^ Globally, an estimated 10%--15% of couples suffer from infertility, and it is estimated that the incidence of male infertility accounts for approximately 50% of all infertile couples.^\[[@R3],[@R4]\]^ However, the causes of male infertility is not fully understood. In addition to environmental and lifestyle risk factors, several genetic causes, such as chromosomal and single-gene alterations, are reported to be associated with male infertility.^\[[@R5]--[@R7]\]^ Current evidence indicates that *GSTM1/T1* gene polymorphism is a potential risk factor.^\[[@R8],[@R9]\]^ Tirumala et al identified an association between the *GSTM1* null genotype and idiopathic male infertility in the Indian population.^\[[@R10]\]^ Olshan et al reported that the *GSTT1* non-null genotype was associated with reduced sperm count in semen.^\[[@R11]\]^

Glutathione-S-transferases (GSTs), a family of eukaryotic and prokaryotic phase II metabolic isozymes, play an essential role in cellular detoxification and bioactivation reactions.^\[[@R12]--[@R14]\]^ There is a high level of GST in human testis and semen, which serves to protect spermatozoa against the negative effects of oxidative stress.^\[[@R8],[@R15]\]^ Mutations in the *GST* gene can affect the activity of the glutathione system enzymes and disturb the balance in the detoxification system, resulting in male infertility.^\[[@R16],[@R17]\]^ Of all published genetic association studies regarding male infertility, GST gene polymorphisms M1 and T1 are the most studied.

A number of studies have investigated the relationship between *GSTM1/T1* gene polymorphism and male infertility risk in various populations worldwide, including Russian, Brazilian, Iranian, Turkish, and Japanese populations. In the Chinese population, several studies have focused on genetic variation in *GSTM1* and *GSTT1* in relation to male infertility, but have yielded contradictory results.

Meta-analysis can combine results of different studies to provide an estimate of the major effect with enhanced precision.^\[[@R18],[@R19]\]^ To date, there has been no meta-analysis of studies conducted in Chinese populations. We perform this meta-analysis on all published case--control studies to derive a more precise estimation of the relationship between *GSTM1/T1* polymorphism and male infertility risk in Chinese populations.

2. Materials and methods
========================

2.1. Identification of relevant studies
---------------------------------------

PubMed, Web of Science, Embase, CBM, CNKI, VIP, and Wang fang databases were searched for studies examining the relation between *GSTM1/GSTT1* gene polymorphisms and male infertility in Chinese population up to April 30, 2018. The search terms were used as follows: "Glutathione S-transferases," "GST," "*GSTM1*," "*GSTT1*," and "male infertility." Besides the database search, the references lists of the relevant studies were also screened for the potential articles that may have been missed in the initial search. All analyses were based on previous published studies, thus no ethical approval and patient consent are required.

2.2. Inclusion and exclusion criteria
-------------------------------------

Studies included in the meta-analysis have to meet the following criteria:

1.  case--control study describing the association of GSTM1/GSTT1 gene polymorphisms and male infertility;

2.  the genotypes in cases and controls were available for the estimation of an odds ratio (OR) with a 95% confidence interval (CI);

3.  the participants were of the Chinese people of all ethnic groups.

Exclusion criteria:

1.  study with incomplete data;

2.  duplicate publications with overlapping data;

3.  editorial articles, review articles, case reports, and meeting abstracts.

2.3. Data extraction and quality assessment
-------------------------------------------

Two investigators extracted the data using a standardized data extraction form independently. Discrepancies were resolved by discussion with a third investigator. The following information was extracted from each study: first author, year of publication, sample size, geographical location, and genotype frequencies of *GSTM1* and *GSTT1.*

The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies by two authors.^\[[@R20]\]^ A star rating system was used to judge methodological quality. Scores range from 0 stars (worst) to 9 stars (best), and studies with a score ≥7 were defined as high quality.

2.4. Statistical analysis
-------------------------

Odds ratios (ORs) with 95% CIs were used to assess the strength of association between *GSTM1/GSTT1* gene polymorphisms and male infertility. The significance of the pooled OR was analyzed by the *Z* test, and *P* \< .05 was considered statistically significant. The heterogeneity among eligible studies was calculated by the Chi-square-based *Q*-test and *I*^2^ statistics. A fixed effect model was used when the *Q* test was *P* \> .05 or *I*^2^ \< 50%, which indicated a statistically significant degree of heterogeneity among the included studies. Otherwise, the random-effects model was used. The Hardy-Weinberg equilibrium (HWE) test could not be conducted, for there was no distribution of null/present heterozygote in each single study included. All statistical analyses were conducted by using Review Manager 5.3 and Stata 14.0. Publication bias was investigated with the funnel plot, Begg\'s test, and Egger\'s test. Sensitivity analysis was performed to assess the stability of the results by sequentially omitted individual studies. *P* \> .05 was considered to indicate statistical significance.

3. Results
==========

3.1. Description of included studies
------------------------------------

A flow diagram of the search process is shown in Figure [1](#F1){ref-type="fig"}. Two hundred and ninety-six related studies were retrieved through database searching. After applying the inclusive and exclusive criteria, 12 case--control studies considering 3557 cases and 2168 controls were included in the meta-analysis.^\[[@R15],[@R17],[@R21]--[@R32]\]^ The publication years of the assessed studies ranged from 2002 to 2015. Of these, 10 case--control studies involving 3302 cases and 1959 controls addressed the *GSTM1* gene polymorphism, and 10 case--control studies involving 3048 cases and 1861 controls addressed the *GSTT1* gene polymorphism. The characteristics of each of the included studies are shown in Table [1](#T1){ref-type="table"}.
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Characteristics of studies included in meta-analysis.
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3.2. Meta-analysis of *GSTM1* null genotype in male infertility susceptibility
------------------------------------------------------------------------------

Ten studies involving a total of 5261 individuals evaluated the influence of the *GSTM1* null genotype on the risk of male infertility. The *I*^2^ value was 76%, which suggested a statistically significant degree of heterogeneity among the studies. Thus, the random effect model was used to synthesize the data. Overall, the results revealed a significant association between the *GSTM1* null genotype and Chinese male infertility (null type vs. present type, OR = 1.35, 95% CI = 1.02--1.78, *P* = .03 in Fig. [2](#F2){ref-type="fig"}). Subgroup analyses on male infertility type showed that significant association was observed in OAT (null type vs. present type, OR = 1.54, 95% CI = 1.04--2.29, *P* = .03 in Fig. [3](#F3){ref-type="fig"}), but not in NOA (null type vs. present type, OR = 0.90, 95% CI = 0.63--1.30, *P* = .57 in Fig. [3](#F3){ref-type="fig"}).
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3.3. Meta-analysis of *GSTT1* null genotype in male infertility susceptibility
------------------------------------------------------------------------------

There were ten studies including 3048 cases and 1861 controls evaluating the influence of the *GSTT1* null genotype on the male infertility. The *I*^2^ value was 55% and the random effect model was applied. Overall, the results revealed a significant association between the *GSTT1* null genotype and Chinese male infertility (null type vs. present type, OR = 1.40, 95% CI = 1.15--1.70, *P* = .0007 in Fig. [4](#F4){ref-type="fig"}). In the subgroup analysis stratified by male infertility type, a significant association was observed for both NOA (null type vs. present type, OR = 1.52, 95% CI = 1.25--1.84, *P* \< .0001 in Fig. [5](#F5){ref-type="fig"}) and OAT patients (null type vs. present type, OR = 1.55, 95% CI = 1.10--2.18, *P* = .01 in Fig. [5](#F5){ref-type="fig"}).
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3.4. Sensitivity and publication bias
-------------------------------------

The sensitivity analyses were performed to calculate the pooled ORs through sequentially excluding individual studies, and the results showed no individual study influenced the overall pooled ORs (Figs. [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}), indicating that the results of this meta-analysis are relatively stable. The publication bias was assessed by funnel plots, Begg\'s test, and Egger\'s test. There was no publication bias for *GSTT1* gene polymorphism (Table [2](#T2){ref-type="table"}, Fig. [8](#F8){ref-type="fig"}). However, some publication bias was observed for *GSTM1* gene polymorphism according to Egger\'s test and funnel plots (Table [2](#T2){ref-type="table"}, Fig. [9](#F9){ref-type="fig"}).
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Publication bias test for *GSTM1/GSTT1* polymorphisms.
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4. Discussion
=============

Oxidative stress induced by reactive oxygen species (ROS) has been widely recognized as one of the major causes of male infertility.^\[[@R33]\]^ Low physiological concentrations of ROS plays an essential role for sperm capacitation, hyperactivation, and spermatozoon-oocyte fusion.^\[[@R34]\]^ GSTs, a major group of detoxification and antioxidant enzymes, are considered to play protective roles against toxic xenobiotic and ROS in tissue.^\[[@R8]\]^ Polymorphisms in the GST gene may impact the ability of protection against oxidative stress and lead to the development of male infertility.^\[[@R35]\]^ In the present study, we examined the association between the polymorphisms of *GSTM1/GSTT1* and the male infertility risk, the overall results showed that the *GSTM1/GSTT1* null genotype might contribute to individual susceptibility to male infertility in Chinese populations. To our knowledge, this is the first meta-analysis to investigate the association between these polymorphisms and the development of male infertility in Chinese population.

There is an increasing evidence investigating the association between *GSTM1/GSTT1* gene polymorphism and risk of male infertility, however, the results remain inconclusive rather than consistent. In 2012, Tang et al conducted a meta-analysis to evaluate the association between *GSTM1/GSTT1* gene polymorphism and idiopathic male infertility risk; they have suggested that the frequency of *GSTM1* null genotype was significantly associated with susceptibility to idiopathic male infertility in Caucasians, but not in Asians, however, no significant association was found between *GSTT1* null genotype and male infertility in both Caucasians and Asians.^\[[@R36]\]^ In 2013, a meta-analysis conducted by Wu et al showed that the frequency of *GSTM1* null genotype was significantly associated with male infertility risk in both Caucasians and Asians. However, the frequency of *GSTT1* null genotype was associated with male infertility risk in Asians other than Caucasians. Due to the differences in the number of participants and different genetic backgrounds, the results provided by each study is not sufficient to draw a convincing conclusion.^\[[@R17]\]^ In our meta-analysis, ten case--control studies (3302 cases and 1959 controls) for the GSTM1 polymorphism, and ten case--control studies (3048 cases and 1861 controls) for the *GSTM1* polymorphism were included to evaluate the relationship of *GSTM1/GSTT1* gene polymorphisms and male infertility risk. The overall results showed that the *GSTM1* null genotype could increase the risk of male infertility in Chinese population (null type vs. present type, OR = 1.35, 95% CI = 1.02--1.78, *P* = .03). It reveals that individuals with the null genotype may have a higher risk for male infertility than those carrying present genotype. Subgroup analysis based on infertility type showed the consistent result. As regard to the *GSTT1* polymorphism, significant association was found with male infertility in the Chinese population (null type vs. present type, OR = 1.40, 95% CI = 1.15--1.70, *P* = .0007), however, subgroup analysis based on infertility type, we have observed that the *GSTT1* null genotype is associated with OAT, but not NOA in Chinese populations. In the present study, Chinese database were searched to more comprehensively assess studies in Chinese populations and more recently-published studies were included in the present meta-analysis, which may underscore the reliability of our findings.

When interpreting the results of the current study, some limitations should be taken with cause. First, the number of included studies was relatively small; therefore, limited data were available. Second, we were unable to analyze gene--gene and gene--environment interactions, due to the lack of information available in the original studies. Third, other factors such as the age, obesity, life-style that may affect the interaction of *GSTM1/GSTT1* gene polymorphism with male infertility could not be analyzed due to the lack of original data.

5. Conclusion
=============

In summary, this meta-analysis provides evidence that the null genotype of *GSTT1* may contribute to genetic susceptibility to the risk of male infertility in Chinese population. The null genotype of *GSTM1* is associated with risk for OAT, but not NOA in Chinese population. Nevertheless, more large sample and representative population-based cases and well-matched controls are needed to validate our results.
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